Research summary, original research, 2018

Noise reduction technology reduces radiation dose in chronic total occlusions percutaneous coronary intervention: a propensity score-matched analysis

Maccagni D, Benincasa S, Bellini B, Candilio L, Poletti E, Carlino M, et al.. The international journal of cardiovascular imaging. 2018

Read the original paper

In plain language

In 55 matched pairs of chronic total occlusion percutaneous coronary intervention (PCI) procedures, an angiographic system with noise reduction technology was associated with lower patient air kerma and similar image quality. Staff dose was not measured.

At a glance

Type of study
Original research, Retrospective cohort study
Who was studied
Patients
Size
n = 110 procedures (55 propensity-matched pairs)
Summary based on
the abstract

What it found

  • Noise reduction technology was associated with lower cumulative air kerma at the interventional reference point than the standard system.

    Key figures: 2.38 (1.80-3.66) vs. 3.24 (2.04-5.09) Gy, p = 0.035

  • Kerma area product showed a non-significant trend towards reduction with noise reduction technology.

    Key figures: 161 (93-244) vs. 203 (136-363) Gycm2, p = 0.069

  • The efficiency index (fluoroscopy time per Gy) was better with noise reduction technology.

    Key figures: 16.75 (12.73-26.27) vs. 13.58 (9.92-17.63) min/Gy, p = 0.003

  • Image quality was similar between systems.

    Key figures: 4.39 ± 0.53 Standard vs. 4.34 ± 0.47 NRT, p = 0.571

Limits to keep in mind

Observational single-system comparison with propensity matching of only 55 pairs; only patient dose metrics were measured, not staff dose, and country and centre details are not given in the abstract.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.